PICARD MEDICAL INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Picard Medical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 08/25/26
Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026GlobeNewsWire • 07/31/26
Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026GlobeNewsWire • 07/27/26
Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing ComplianceGlobeNewsWire • 07/22/26
Picard Medical, Inc. (PMI) Shareholder/Analyst Call Prepared Remarks TranscriptSeeking Alpha • 07/17/26
Artificial Organs Publishes Independent Commentary on Picard Medical and SynCardia's Emperor Total Artificial Heart ProgramGlobeNewsWire • 07/15/26
Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual MeetingGlobeNewsWire • 07/13/26
WSJ Intelligence Study: Uniquely Human Skills Deemed "Non-Replicable" in Automated FutureBusiness Wire • 06/23/26
Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026GlobeNewsWire • 06/16/26
Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant StudiesGlobeNewsWire • 06/02/26
Picard Medical / SynCardia Recognizes Banner Health as Global Leader and Supporter in the Advancement of Total Artificial Heart TechnologyGlobeNewsWire • 04/30/26
Picard Medical / SynCardia Featured in Interview Series with The Mullings GroupGlobeNewsWire • 04/29/26
Picard Medical / SynCardia to Present Next Generation Total Artificial Heart Platform at ISHLT 2026 in TorontoGlobeNewsWire • 04/16/26